Skip to content

David Baxley Spetzler, President at Caris Life Sciences, sold CAI on Sep 4, 2026

Data as of Oct 16

▼ SELL$3M119,212 shares at $24.76David Baxley Spetzler PresidentCAI Caris Life Sciences, Inc.
Watch CAI
Traded
Sep 4, 2026
Disclosed
Sep 4, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

David Baxley Spetzler, President at Caris Life Sciences, sold CAI on Sep 4, 2026TRADEDDISCLOSED
CAISimilar stocks (XLV — its sector index fund), rebased to CAI's price on the disclosure day
CAI since disclosure
+21.9%
after the sale
Similar stocks (XLV) since disclosure
+3.1%
XLV — its sector index fund

Change in closing price from Sep 4, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLDavid Baxley Spetzler PresidentCAI Caris Life Sciences, Inc.$9.7Mdisclosed Sep 4 · filed 1 day after the trade
  2. ▼ SELLDavid Baxley Spetzler PresidentCAI Caris Life Sciences, Inc.$2.1Mdisclosed Sep 4 · filed 1 day after the trade

See every trade on CAI →